newsfilter
← Latest News
ClinicalTrials.gov·

Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3) - NCT05764239

To assess the percentage change in blood phenylalanine (Phe) level, To evaluate efficacy of SYNB1934 versus placebo in the responder population through the change from baseline to Week 4 in blood Phe level., To assess the absolute change in Phe level, (and 4 more...)